Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

about

Total Phosphate Elimination is Negatively Associated With Increased Serum Fibroblast Growth Factor 23 Levels in Patients who Undergo Peritoneal Dialysis.Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome

P2860

Q51197552-A32CCECA-DEF2-4EEB-A165-4A86889D02DB Q53378011-C1EE804D-9481-49AD-B4A9-C4E5154ED3CE Q58773641-CBCF9CEB-E505-405F-8D24-C171620AD0F8

P2860

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

Item

http://www.wikidata.org/entity/Q50636871

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

@en

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

@nl

type

Item

label

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

@en

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

@nl

prefLabel

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

@en

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

@nl

P1476

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

@en

P2093

Curie Ahn

http://www.w3.org/2001/XMLSchema#string

Dong Ki Kim

http://www.w3.org/2001/XMLSchema#string

Hayne Cho Park

http://www.w3.org/2001/XMLSchema#string

Hyo Jin Kim

http://www.w3.org/2001/XMLSchema#string

Jaeseok Yang

http://www.w3.org/2001/XMLSchema#string

Jong Cheol Jeong

http://www.w3.org/2001/XMLSchema#string

Kook-Hwan Oh

http://www.w3.org/2001/XMLSchema#string

Kwon Wook Joo

http://www.w3.org/2001/XMLSchema#string

Miseon Park

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of aortic stiffness on survival in end-stage renal disease.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis patients.

Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis.

P304

26-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/PDI.2013.00343

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Young-Hwan Hwang

P577

2014-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25185018

http://www.w3.org/2001/XMLSchema#string

P932

4737562

http://www.w3.org/2001/XMLSchema#string

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

about

P2860

P2860

Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932